Advertisement
Screener

REPLIGEN CORP (RGEN) Net Margin

REPLIGEN CORP Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • REPLIGEN CORP net margin for the quarter ending 2026-06-30 was 2.45%, a 69.90% decline year-over-year.
  • REPLIGEN CORP net margin for the quarter ending 2026-03-31 was 4.29%, a 24.48% increase year-over-year.
  • REPLIGEN CORP net margin for the quarter ending 2025-12-31 was 6.71%, a change of 26.93% year-over-year.
  • REPLIGEN CORP net margin for the quarter ending 2025-09-30 was 7.90%, a change of 8.32% year-over-year.
  • REPLIGEN CORP net margin for fiscal 2025 was 6.62%, a change of 10.64% from fiscal 2024.
  • REPLIGEN CORP net margin for fiscal 2024 was -4.02%, a 171.44% decline from fiscal 2023.
  • REPLIGEN CORP net margin for fiscal 2023 was 5.63%, a 75.74% decline from fiscal 2022.
  • REPLIGEN CORP net margin for fiscal 2022 was 23.20%, a 21.26% increase from fiscal 2021.
Available history
2010-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2026-06-302.45%$5.01M$204.13M
2026-03-314.29%$8.33M$194.26M
2025-12-316.71%$13.29M$197.91M
2025-09-307.90%$14.91M$188.81M
2025-06-308.15%$14.87M$182.37M
2025-03-313.45%$5.83M$169.17M
2024-12-31-20.21%-$33.87M$167.55M
2024-09-30-0.42%-$654,000.00$154.87M
2024-06-303.60%$5.71M$158.84M
2024-03-312.15%$3.3M$153.18M
2023-12-31-9.87%-$16.45M$166.62M
2023-09-3011.99%$16.92M$141.19M
2023-06-3012.43%$19.79M$159.17M
2023-03-319.27%$15.34M$165.38M
2022-12-3126.09%$48.73M$186.76M
2022-09-3020.13%$40.41M$200.74M
2022-06-3024.01%$49.86M$207.63M
2022-03-3122.75%$46.96M$206.4M
2021-12-3115.61%$29.11M$186.52M
2021-09-3018.80%$33.5M$178.22M
2021-06-3022.23%$36.23M$162.96M
2021-03-3120.62%$29.45M$142.84M
2020-12-3118.13%$19.7M$108.65M
2020-09-3015.47%$14.55M$94.06M
2020-06-3018.13%$15.86M$87.46M
2020-03-3112.90%$9.82M$76.09M
2019-12-315.19%$3.6M$69.47M
2019-09-302.39%$1.66M$69.45M
2019-06-3011.45%$8.1M$70.69M
2019-03-3113.28%$8.05M$60.63M
2018-12-3110.85%$5.64M$51.94M
2018-09-309.68%$4.79M$49.53M
2018-06-305.74%$2.74M$47.73M
2018-03-317.69%$3.45M$44.83M
2017-12-3129.27%$12.18M$41.61M
2017-09-3012.76%$4.67M$36.58M
2017-06-3026.00%$8.44M$32.46M
2017-03-3110.03%$3.07M$30.59M
2016-12-3119.65%$5.03M$25.6M
2016-09-304.68%$1.16M$24.68M
2016-06-3013.27%$3.87M$29.17M
2016-03-316.48%$1.63M$25.09M
2015-12-311.24%$265,000.00$21.45M
2015-09-3012.81%$2.54M$19.81M
2015-06-3016.83%$3.61M$21.46M
2015-03-3114.08%$2.93M$20.82M
2014-12-31-2.43%-$399,000.00$16.39M
2014-09-309.60%$1.47M$15.28M
2014-06-3018.17%$2.83M$15.55M
2014-03-3126.20%$4.28M$16.33M
2013-12-3121.63%$3.33M$15.38M
2013-09-3031.28%$5.89M$18.82M
2013-06-3025.92%$4.54M$17.51M
2013-03-3114.21%$2.34M$16.46M
2012-12-3150.78%$9.55M$18.81M
2012-09-3011.96%$1.81M$15.1M
2012-06-3010.11%$1.57M$15.52M
2012-03-319.56%$1.23M$12.82M
2011-09-307.01%$604,673.00$8.63M
2011-06-30-0.73%-$55,597.00$7.65M
2011-03-31-34.38%-$2.03M$5.91M
2010-09-308.53%$623,209.00$7.31M
2010-06-3014.10%$988,053.00$7.01M

Annual Net Margin

DateNet MarginNet incomeRevenue
2025-12-316.62%$48.89M$738.26M
2024-12-31-4.02%-$25.51M$634.44M
2023-12-315.63%$35.6M$632.36M
2022-12-3123.20%$185.96M$801.54M
2021-12-3119.13%$128.29M$670.53M
2020-12-3116.36%$59.93M$366.26M
2019-12-317.92%$21.41M$270.25M
2018-12-318.56%$16.62M$194.03M
2017-12-3120.07%$28.35M$141.24M
2016-12-3111.17%$11.68M$104.54M
2015-12-3111.19%$9.35M$83.54M
2014-12-3112.86%$8.17M$63.55M
2013-12-3123.61%$16.09M$68.17M
2012-12-3122.73%$14.16M$62.27M
2011-03-31-0.16%-$43,509.00$27.29M
2010-03-31-19.38%-$4.06M$20.97M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78